Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) — Stock Score Summary

Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) has a MoatMap StockRank of 31/100 based on Quality (41/100), Value (27/100), and Momentum (50/100) factor scores. The current signal is SELL. Hunan Er-Kang is a pharmaceutical excipient manufacturer. It lacks the scale, regulatory moat, and advanced manufacturing capabilities required to benefit from our CDMO pricing power theme.

Hunan Er-Kang Pharmaceutical Co., Ltd. is a leading manufacturer of pharmaceutical excipients, active pharmaceutical ingredients (APIs), and finished drug formulations. The company is a pioneer and global leader in starch-based empty capsules, offering a natural, plant-derived alternative to traditional gelatin capsules. Its comprehensive product portfolio and strict compliance with international GMP standards secure its dominant position in the domestic pharmaceutical excipient market.

Key Financial Metrics

Price$0.51
Market Cap$1.1B
P/E (Forward)4.46
Price/Book1.78
Return on Equity-9.9%
Return on Invested Capital-8.9%
Debt/Equity18.11
Gross Margin22.6%
Operating Margin2.3%
Revenue Growth-30.0%
Free Cash Flow$2M

Hunan Er-Kang Pharmaceutical Co., Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hunan Er-Kang Pharmaceutical Co., Ltd’s (300267.SZ) StockRank?
MoatMap’s StockRank for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) is 31/100, with a Sell signal. It is a composite of Quality (41), Value (27), and Momentum (50) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hunan Er-Kang Pharmaceutical Co., Ltd have an economic moat?
Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hunan Er-Kang Pharmaceutical Co., Ltd a buy, hold, or sell?
MoatMap’s current signal for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hunan Er-Kang Pharmaceutical Co., Ltd in?
Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks300267.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock